Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening

Recruiting now · Not applicable

Conditions studied: Hereditary Cancer Syndromes

In brief

The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.

Key facts

Study ID
NCT07052266
Run by
Weill Medical College of Cornell University
People needed
550
Starts
2025-09-02
Expected to finish
2028-12-01
Last updated by the study team
2025-12-26

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.